Literature DB >> 24438144

Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines.

Keiji Iwatsuki1, Toshihisa Hamada.   

Abstract

The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) - Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. The JDA/JSCS guidelines are unique because they describe information and management practices for lymphomas specific to Asia, such as adult T-cell leukemia/lymphoma and extranodal natural killer/T-cell lymphoma, nasal type. In the present article, we have highlighted the essential points of management for cutaneous lymphomas in Asia. In order to complement the guidelines, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  adult T-cell leukemia/lymphoma; extranodal natural killer/T-cell lymphoma; guideline; interferon-γ; mycosis fungoides; vorinostat

Mesh:

Year:  2014        PMID: 24438144     DOI: 10.1111/1346-8138.12346

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).

Authors:  Toshihisa Hamada; Yoshiki Tokura; Makoto Sugaya; Mikio Ohtsuka; Ryoji Tsuboi; Tetsuo Nagatani; Eiji Kiyohara; Mamori Tani; Mitsuru Setoyama; Shigeto Matsushita; Kazuhiro Kawai; Kentaro Yonekura; Toshiaki Saida; Keiji Iwatsuki
Journal:  J Dermatol       Date:  2019-05-15       Impact factor: 4.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.